Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...

Wegovy’s starting dosage is a 0.25-milligram (mg) injection once per week. You’ll typically increase your dose every 4 weeks, up to 1.7 mg per week or 2.4 mg per week.

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...